Global Spine Biologics Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.

Scope of the Report:
North America region is the largest supplier of Spine Biologics, with a production market share nearly 63%. Europe is the second largest supplier of Spine Biologics, enjoying production market share nearly 28%.
North America is the largest consumption place, with a consumption market share nearly 61%. Following North America, Europe is the second largest consumption place with the consumption market share of 21%.
Market competition is not intense. Medtronic, Depuy Synthes, Stryker Corporation, Nuvasive and Zimmer Biomet etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers, have been formed in the monopoly position in the industry. The Market Share of Medtronic is 40% in 2015.
With the development of medical technology level, more and more companies participate in this industry. For example, Spine Biologics of EnteroMedics and Inspire Medical have been approved by FDA in 2015.

The worldwide market for Spine Biologics is expected to grow at a CAGR of roughly 3.6% over the next five years, will reach 2550 million US$ in 2024, from 2060 million US$ in 2019, according to a new study.
This report focuses on the Spine Biologics in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Medtronic
Depuy Synthes
Stryker Corporation
Nuvasive
Zimmer Biomet
Orthofix International
Globus Medical
alphatec spine
K2M
Exactech
Wright Medical Technology
X-Spine
Nutech
Arthrex

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Bone Graft
Bone Graft Substitute
Platelet Rich Plasma (PRP)
BMAC (Bone Marrow Aspirate Concentrate)

Market Segment by Applications, can be divided into
Anterior Cervical Discectomy and Fusion
Posterior Lumbar Interbody Fusion
Other

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Spine Biologics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Spine Biologics, with price, sales, revenue and global market share of Spine Biologics in 2017 and 2018.
Chapter 3, the Spine Biologics competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Spine Biologics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Spine Biologics market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Spine Biologics sales channel, distributors, customers, research findings and conclusion, appendix and data source.